The information on this page has been prepared with reference to published scientific literature, not by a medically qualified expert. It is not medical advice. Any decision to use a supplement or herb-based product is your responsibility. Consult a suitably qualified medical professional, especially if you have underlying conditions. Remember, nothing is for everyone, and not everything sold is what it claims to be. Some things work for some people, some of the time.
Cow parsley (Anthriscus sylvestris), also known as wild chervil, wild beaked parsley, or keck, is a flowering plant in the Apiaceae family native to Europe, Western Asia, and Northwestern Africa. It should not be confused with garden chervil (Anthriscus cerefolium), which is closely related but distinct, or with other similar-looking plants such as hemlock (Conium maculatum), which is highly toxic, or Queen Anne's lace/wild carrot (Daucus carota).
Despite its traditional use in some folk medicine practices, there is a significant lack of robust clinical research on cow parsley. Most available studies are preliminary in vitro or animal studies, with very few human clinical trials. This creates substantial knowledge gaps regarding efficacy, safety, and appropriate dosing in humans.
The limited research suggests several potential properties that require further study:
It's important to note that these findings are preliminary and have not translated to proven therapeutic applications in humans. No credible peer-reviewed research demonstrates that cow parsley "cures" any medical condition.
No standardized or evidence-based dosing protocols exist for cow parsley. The lack of clinical trials means there is insufficient data to establish safe and effective dosage ranges for any medical purpose. The absence of standardization in existing preparations further complicates dosing considerations.
Studies examining doses above any theoretical "therapeutic" range are non-existent in peer-reviewed literature. This represents a critical knowledge gap regarding toxicity thresholds and potential cumulative effects.
There are currently no FDA-approved or EMA-approved pharmaceutical medications containing cow parsley extracts or compounds derived from cow parsley. Unlike some other medicinal plants that have led to pharmaceutical development, cow parsley has not been successfully developed into regulated pharmaceutical products.
Research into cow parsley remains in early preclinical stages. No meta-analyses specifically focusing on cow parsley's medicinal properties were identified in peer-reviewed literature between 2020-2024. The plant has received limited attention from the pharmaceutical research community compared to other medicinal plants.
While cow parsley contains bioactive compounds with theoretical potential, there is insufficient scientific evidence to support its use for any specific health condition. The significant risk of misidentification with highly toxic lookalike plants, combined with the lack of standardization and clinical safety data, raises substantial safety concerns. Individuals interested in plant-based therapies should consult healthcare providers about evidence-based alternatives with established safety and efficacy profiles.
Kim, S. B., Lee, A. Y., Chun, J. M., Lee, A. R., Kim, H. S., Seo, Y. S., ... & Kwon, B. I. (2019). Anthriscus sylvestris root extract reduces allergic lung inflammation by regulating interferon regulatory factor 4-mediated Th2 cell activation. Journal of ethnopharmacology, 232, 165-175.
Lee, S. A., Moon, S. M., Han, S. H., Hwang, E. J., Hong, J. H., Park, B. R., ... & Kim, C. S. (2018). In vivo and in vitro anti-inflammatory effects of aqueous extract of Anthriscus sylvestris leaves. Journal of medicinal food, 21(6), 585-595.
Lee, S. A., Moon, S. M., Han, S. H., Hwang, E. J., Park, B. R., Kim, J. S., ... & Kim, C. S. (2018). Chondroprotective effects of aqueous extract of Anthriscus sylvestris leaves on osteoarthritis in vitro and in vivo through MAPKs and NF-κB signaling inhibition. Biomedicine & Pharmacotherapy, 103, 1202-1211.
Olaru, O. T., Niţulescu, G. M., Orțan, A., & Dinu-Pîrvu, C. E. (2015). Ethnomedicinal, phytochemical and pharmacological profile of Anthriscus sylvestris as an alternative source for anticancer lignans. Molecules, 20(8), 15003-15022.
Orčić, D., Berežni, S., & Mimica-Dukić, N. (2022). Phytochemical and biochemical studies of wild chervil (Anthriscus sylvestris). Biologia Serbica, 44(1).
Zhang, M., Ji, X., Li, Y., Chen, X., Wu, X., Tan, R., & Jiang, H. (2024). Anthriscus sylvestris: An overview on Bioactive Compounds and Anticancer Mechanisms from a Traditional Medicinal Plant to Modern Investigation. Mini Reviews in Medicinal Chemistry, 24(12), 1162-1176.